cenerimod
idorsia pharmaceuticals
['cenerimod', '#1656']
askanase et al. phase 2 rct cenerimod (s1p modulator) in sle. primary endpoint not met. some suggestion of efficacy at highest 4mg dose. but if its already like this in a phase 2, i doubt a phase 3 will bring better results #acr22 abstr#1656 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC